- Home
- CHW vs TMCI Comparison
CHW vs TMCI Comparison
Compare CHW & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHW
- TMCI
- Stock Information
- Founded
- CHW 2007
- TMCI 2014
- Country
- CHW United States
- TMCI United States
- Employees
- CHW N/A
- TMCI N/A
- Industry
- CHW Investment Managers
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CHW Finance
- TMCI Health Care
- Exchange
- CHW Nasdaq
- TMCI Nasdaq
- Market Cap
- CHW 431.1M
- TMCI 464.4M
- IPO Year
- CHW N/A
- TMCI 2021
- Fundamental
- Price
- CHW $6.83
- TMCI $8.71
- Analyst Decision
- CHW
- TMCI Hold
- Analyst Count
- CHW 0
- TMCI 8
- Target Price
- CHW N/A
- TMCI $8.84
- AVG Volume (30 Days)
- CHW 195.2K
- TMCI 291.6K
- Earning Date
- CHW 01-01-0001
- TMCI 02-27-2025
- Dividend Yield
- CHW 9.27%
- TMCI N/A
- EPS Growth
- CHW N/A
- TMCI N/A
- EPS
- CHW N/A
- TMCI N/A
- Revenue
- CHW N/A
- TMCI $202,861,000.00
- Revenue This Year
- CHW N/A
- TMCI $13.18
- Revenue Next Year
- CHW N/A
- TMCI $8.61
- P/E Ratio
- CHW N/A
- TMCI N/A
- Revenue Growth
- CHW N/A
- TMCI 16.14
- 52 Week Low
- CHW $5.07
- TMCI $3.92
- 52 Week High
- CHW $6.54
- TMCI $15.98
- Technical
- Relative Strength Index (RSI)
- CHW 48.22
- TMCI 63.78
- Support Level
- CHW $6.64
- TMCI $8.16
- Resistance Level
- CHW $6.81
- TMCI $8.64
- Average True Range (ATR)
- CHW 0.10
- TMCI 0.48
- MACD
- CHW 0.01
- TMCI 0.12
- Stochastic Oscillator
- CHW 46.34
- TMCI 93.09
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment strategy is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities and alternative investments.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.